| Name: | ID: | Time: | Location: | Title: |
|---|---|---|---|---|
|
Bajaj |
LBP-009 |
08:30-08:30 |
Poster |
Globally derived and externally validated cut offs for liver failure and inclusion of infections improve prognostication for inpatient death: towards ACLF harmonization
|
|
Bajaj |
WED-060 |
08:30-08:30 |
Poster |
Gut microbial antibiotic resistance genes in clinicians taking care of cirrhosis patients shows wide variation according to country income and could be a risk factor for bidirectional transmission |
|
Bajaj |
WED-061 |
08:30-08:30 |
Poster |
Gut metagenomic profiles predict 90-day hospitalizations despite controlling for diet, demographics & cirrhosis details in a multi-country cohort of patients with cirrhosis |
|
Bajaj |
THU-157 |
08:30-08:30 |
Poster |
Novel potential metabolomic mechanisms for albumin-related improvement in cognitive function in patients with patients with hepatic encephalopathy |
|
Sanyal |
WED-494 |
08:30-08:30 |
Poster |
Development and validation of two NIS2+®-based models for the detection of MASH resolution and fibrosis improvement |
|
Sanyal |
|
13:30-13:50 |
Erlinger |
The future of MASH epidemiology in light of the increasing treatment of obesity |
|
Sanyal |
|
13:50-14:10 |
Erlinger |
How high is the bar to prevent fibrosis progression in patients with advanced MASH? |
|
Sanyal |
|
14:10-14:30 |
Erlinger |
Emerging concepts in comprehensive clinical management of patients with MASH and advanced fibrosis |
EASL Congress 2025
Institute Director Arun Sanyal, M.D., will lead our faculty at the EASL Congress 2025 in Amsterdam, May 7-10.
VCU @ EASL day by day
To see the full list of VCU's presence at EASL Congress 2025, select a date below:
Wednesday, May 7
Thursday, May 8
| Name: | ID: | Time: | Location: | Title: |
|---|---|---|---|---|
|
Bajaj |
LBP-009 |
08:30-08:30 |
Poster |
Globally derived and externally validated cut offs for liver failure and inclusion of infections improve prognostication for inpatient death: towards ACLF harmonization
|
|
Bajaj |
WED-060 |
08:30-08:30 |
Poster |
Gut microbial antibiotic resistance genes in clinicians taking care of cirrhosis patients shows wide variation according to country income and could be a risk factor for bidirectional transmission |
|
Bajaj |
WED-061 |
08:30-08:30 |
Poster |
Gut metagenomic profiles predict 90-day hospitalizations despite controlling for diet, demographics & cirrhosis details in a multi-country cohort of patients with cirrhosis |
|
Bajaj |
THU-157 |
08:30-08:30 |
Poster |
Novel potential metabolomic mechanisms for albumin-related improvement in cognitive function in patients with patients with hepatic encephalopathy |
|
Hoang, Min, Seneshaw, Mirshahi, Sanyal |
THU-493 |
08:30-08:30 |
Poster |
miRNA isoforms are differentially expressed with increasing disease activity and fibrosis in metabolic dysfunction-associated steatotic liver disease |
Friday, May 9
| Name: | ID: | Time: | Location: | Title: |
|---|---|---|---|---|
|
Sanyal, Hoang, Mirshahi, Siddiqui, Asgharpour |
FRI-341 |
08:30-08:30 |
Poster |
miRNA isoforms are differentially expressed with increasing disease activity and fibrosis in metabolic dysfunction-associated steatotic liver disease |
|
Aseem |
FRI-326 |
08:30-08:30 |
Poster |
Spatial transcriptomic analysis of archived primary sclerosing cholangitis livers reveals distinct molecular signatures |
|
Bajaj |
FRI-185 |
08:30-08:30 |
Poster |
Outpatient sbp prophylaxis associates with higher sbp reccurence in a global cohort of cirrhosis inpatients with greatest impact in high- income countries
|
|
Bajaj |
FRI-186 |
08:30-08:30 |
Poster |
Rifaximin use does not significantly affect the rate of 30-day mortality or liver transplant in patients with cirrhosis on Daptomycin in two national US-based cohorts |
|
Sanyal, Bajaj |
FRI-193 |
08:30-08:30 |
Poster |
A machine-learning algorithm using real-world data identified subpopulations at risk for adverse outcomes in patients with acute-on-chronic liver failure |
|
Bajaj
|
OS-040 |
17:00-17:15 |
Erlinger |
Acute-on-chronic kidney disease in cirrhosis- a global study |
Saturday, May 10
| Name: | ID: | Time: | Location: | Title: |
|---|---|---|---|---|
|
Bajaj |
|
08:38-08:53 |
Benhamou |
Epidemiology and clinical impact of MDR infections in decompensated cirrhosis |
|
Luketic |
OS-089 |
11:15-11:30 |
McIntyre |
Elafibranor for primary sclerosing cholangitis: the ELMWOOD phase II randomised controlled trial |